Literature DB >> 7477907

Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors.

S Brené1, H Hall, N Lindefors, P Karlsson, C Halldin, G Sedvall.   

Abstract

Messenger RNAs for the D1 dopamine receptor and dopamine- and cyclic AMP-regulated phosphoprotein of relative mass 32,000 (DARPP-32) were examined by in situ hybridization in the cynomolgus monkey brain. The messenger RNA distribution was compared to the distribution of D1 dopamine receptors using [3H]SCH 23390 autoradiography. In the caudate nucleus and putamen, D1 dopamine receptor messenger RNA-positive cells were unevenly distributed. Clusters of cells with an approximately three-fold higher intensity of labeling, as compared to surrounding regions, were found. Some of these D1 dopamine receptor messenger RNA intensive cell clusters in the caudate nucleus appeared to some extent to be matched to regions of higher intensity of [3H]SCH 23390 binding. The distribution of cells expressing DARPP-32 messenger RNA in the caudate nucleus and putamen was found to be non-clustered. In neocortical regions, cells of different sizes expressing D1 dopamine receptor messenger RNA were present in layers II-VI. D1 dopamine receptor messenger RNA-positive cells were most abundant in layer V. Unexpectedly, no DARPP-32 messenger RNA signal was detected in neocortex. Chronic SCH 23390 administration did not change the relative levels of messenger RNAs for the D1 dopamine receptor and DARPP-32 or [3H]SCH 23390 binding as measured by quantitative image analysis. The clustered distribution of D1 dopamine receptor messenger RNA is in contrast to that of DARPP-32 messenger RNA. This suggests that D1 dopamine receptors may play a more significant role in regulating DARPP-32 function in patch regions as compared to matrix regions. D1 dopamine receptor messenger RNA-expressing cells could also be visualized in several layers of the primate neocortex, implying that dopamine acts through D1 dopamine receptors within functionally different neuronal circuits of the neocortex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477907     DOI: 10.1016/0306-4522(95)00037-j

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

Review 1.  Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.

Authors:  Arabo Avanes; Gal Lenz; Jamil Momand
Journal:  Biochem Pharmacol       Date:  2018-12-12       Impact factor: 5.858

2.  Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.

Authors:  Y Kunii; T M Hyde; T Ye; C Li; B Kolachana; D Dickinson; D R Weinberger; J E Kleinman; B K Lipska
Journal:  Mol Psychiatry       Date:  2013-01-08       Impact factor: 15.992

3.  Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.

Authors:  Yasuto Kunii; Keiko Ikemoto; Akira Wada; Qiaohui Yang; Takashi Kusakabe; Toshimitsu Suzuki; Shin-Ichi Niwa
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

Review 4.  The involvement of DARPP-32 in the pathophysiology of schizophrenia.

Authors:  Haitao Wang; Mohd Farhan; Jiangping Xu; Philip Lazarovici; Wenhua Zheng
Journal:  Oncotarget       Date:  2017-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.